Complete Filing Data
Oculis Holding AG reported Cash And Cash Equivalents of $81.33 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oculis Holding AG did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue And Operating Income | $1.2M | $686.0K | $883.0K | $912.0K | $960.0K | $993.0K |
| Research And Development Expense | $57.1M | $52.1M | $29.2M | $22.2M | $9.6M | $9.3M |
| Profit Loss From Operating Activities | -$81.7M | -$73.2M | -$80.7M | -$32.4M | -$13.2M | -$12.3M |
| Profit Loss Before Tax | -$99.1M | -$85.9M | -$88.7M | -$38.6M | -$18.5M | -$14.8M |
| Profit Loss | -$99.0M | -$85.8M | -$88.8M | -$38.7M | -$18.6M | -$14.9M |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $599.0K | -$1.2M | -$808.0K | $744.0K | $88.0K | -$115.0K |
| Other Comprehensive Income | $390.0K | -$1.1M | -$835.0K | $747.0K | $60.0K | -$87.0K |
| Income Tax Expense Continuing Operations | -$186.0K | -$160.0K | $107.0K | $55.0K | $27.0K | $83.0K |
| General And Administrative Expense | $25.8M | $21.8M | $17.5M | $11.1M | $4.6M | $4.0M |
| Comprehensive Income | -$98.6M | -$86.9M | -$89.6M | -$38.0M | -$18.5M | -$15.0M |
| Adjustments For Interest Expense | $1.3M | $6.3M | $5.0M | $2.6M | ||
| Income Taxes Paid Classified As Operating Activities | $152.0K | $101.0K | $20.0K | |||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation Other Than Translation Of Foreign Operations | $3.0K | -$28.0K | $28.0K | |||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $3.0K | -$28.0K | $28.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $81.3M | $27.7M | $38.3M | $19.8M | $46.3M | $5.0M | $12.2M |
| Accrued Income Including Contract Assets | $993.0K | $629.0K | $876.0K | $912.0K | $760.0K | $993.0K | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $301.0K | $230.0K | $48.0K | $65.0K | $28.0K | $19.0K | |
| Intangible Assets Other Than Goodwill | $13.3M | $13.3M | $12.2M | $12.2M | $8.7M | $8.7M | |
| Cash Flows From Used In Operating Activities | -$66.3M | -$48.9M | -$55.0M | -$25.1M | -$13.8M | -$12.0M | |
| Cash Flows From Used In Investing Activities | -$60.9M | -$16.1M | -$53.0M | -$3.5M | -$28.0K | -$19.0K | |
| Cash Flows From Used In Financing Activities | $186.9M | $54.0M | $129.6M | $1.7M | $55.2M | $4.9M | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $101.0K | -$36.0K | -$171.0K | -$9.0K | -$139.0K | $77.0K | |
| Adjustments For Decrease Increase In Other Current Assets | $2.3M | $5.0M | -$5.6M | -$1.8M | -$731.0K | $169.0K | |
| Adjustments For Decrease Increase In Accrued Income Other Than Contract Assets | -$364.0K | $247.0K | $36.0K | -$152.0K | $233.0K | $230.0K | |
| Rightofuse Assets | $2.5M | $1.3M | $755.0K | $758.0K | $855.0K | $948.0K | |
| Adjustments For Increase Decrease In Trade Account Payable | -$1.7M | $3.7M | $3.0M | $30.0K | -$649.0K | ||
| Adjustments For Decrease Increase In Accrued Expenses And Other Payables | $11.1M | -$11.5M | $4.9M | -$352.0K | -$211.0K | ||
| Trade And Other Current Payables | $1.8M | $5.9M | $7.6M | $3.9M | $824.0K | ||
| Retained Earnings | -$384.5M | -$285.6M | -$199.8M | -$111.0M | -$72.3M | ||
| Property Plant And Equipment | $534.0K | $385.0K | $288.0K | $365.0K | $431.0K | ||
| Noncurrent Liabilities | $3.1M | $2.7M | $1.5M | $123.0M | $114.9M | ||
| Noncurrent Lease Liabilities | $1.8M | $865.0K | $431.0K | $491.0K | $577.0K | ||
| Noncurrent Assets | $17.1M | $15.5M | $13.3M | $13.4M | $10.1M | ||
| Liabilities | $39.9M | $47.0M | $20.6M | $135.1M | $119.0M | ||
| Equity And Liabilities | $236.0M | $120.4M | $114.4M | $37.1M | $58.0M | ||
| Current Liabilities | $36.7M | $44.2M | $19.1M | $12.0M | $4.1M | ||
| Current Lease Liabilities | $502.0K | $315.0K | $174.0K | $142.0K | $193.0K | ||
| Current Assets | $218.9M | $104.9M | $101.0M | $23.7M | $48.0M | ||
| Current Accrued Expenses And Other Current Liabilities | $20.0M | $18.2M | $5.9M | $8.0M | $3.0M | ||
| Assets | $236.0M | $120.4M | $114.4M | $37.1M | $58.0M | ||
| Adjustments For Interests On Lease Liabilities | $42.0K | $45.0K | $49.0K | $50.0K | |||
| Other Current Assets | $4.9M | $5.6M | $8.5M | $3.0M | $944.0K | ||
| Adjustments For Depreciation Expense Right Of Use Assets | $162.0K | $167.0K | $147.0K | $124.0K | |||
| Other Noncurrent Financial Liabilities | $122.4M | $113.5M | $54.0M | ||||
| Fair Value Adjustment On Warrant Liabilities | -$12.3M | -$15.5M | -$3.4M | ||||
| Current Warrant Liability | $14.5M | $19.9M | $5.4M | ||||
| Recognised Liabilities Defined Benefit Plan | $728.0K | $91.0K | $845.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $373.0K | $274.0K | $158.0K | $159.0K | $98.0K | $98.0K |
| Increase Decrease In Cash And Cash Equivalents | $59.7M | -$11.0M | $21.6M | -$26.9M | $41.3M | -$7.2M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$6.1M | $407.0K | -$3.1M | $418.0K | -$16.0K | -$12.0K |
| Proceeds From Issue Of Preference Shares | 2.0M | 56.1M | 5.0M | |||
| Proceeds From Issue Of Ordinary Shares | 178.9M | 53.5M | 38.2M | 120.0K | ||
| Proceeds From Exercise Of Options | $1.9M | $938.0K | $274.0K | $120.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-1.89 | $-2.12 | $-2.97 | $-11.32 | $-5.84 | $-5.77 |
| Basic Earnings Loss Per Share | $-1.89 | $-2.12 | $-2.97 | $-11.32 | $-5.84 | $-5.77 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Expense | $82.9M | $73.9M | $81.6M | $33.3M | $14.2M | $13.3M |
| Gains Losses On Exchange Differences On Translation Before Tax | -$6.1M | $1.3M | -$4.7M | $49.0K | -$193.0K | $163.0K |
| Finance Income Cost | -$17.5M | -$12.7M | -$8.0M | -$6.3M | -$5.3M | -$2.5M |
| Finance Income | $1.8M | $2.2M | $1.4M | $126.0K | $21.0K | $10.0K |
| Finance Costs | $833.0K | $639.0K | $1.3M | $6.4M | $5.1M | $2.6M |
| Reserve Of Sharebased Payments | $30.4M | $16.1M | $6.4M | $2.8M | $2.0M | $1.6M |
| Increase Decrease Through Sharebased Payment Transactions | $16.0M | $9.8M | $3.6M | $804.0K | $328.0K | $328.0K |
| Adjustments For Sharebased Payments | $16.0M | $9.8M | $3.6M | $804.0K | $328.0K | $328.0K |
| Adjustments For Depreciation Expense | $546.0K | $406.0K | $287.0K | $299.0K | $88.0K | $104.0K |
| Grant Income | $883.0K | $912.0K | $960.0K | $993.0K | ||
| Share Premium | $551.7M | $344.9M | $288.2M | $10.7M | $10.4M | |
| Reserve Of Exchange Differences On Translation | -$480.0K | -$271.0K | -$327.0K | -$300.0K | -$303.0K | |
| Issued Capital | $587.0K | $446.0K | $366.0K | $39.0K | $335.0K | |
| Actuarial Loss On Post Employment Benefit Obligations | -$1.6M | -$2.2M | -$1.1M | -$264.0K | -$1.0M | |
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$209.0K | $56.0K | -$5.0M | $3.0K | -$28.0K | |
| Adjustments For Net Financial Result | $3.5M | -$500.0K | $53.0K | -$155.0K | ||
| Treasury Shares | 7.0K | 10.0K | 1.0K | 100.0K | ||
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$30.0K | $583.0K | -$792.0K | $28.0K | ||
| Interest Paid Classified As Operating Activities | $100.0K | $116.0K | $58.0K | |||
| Increase Decrease Through Transaction Costs | -$9.0K | -$12.0K | -$15.0K | |||
| Transaction Costs For Issuance Of Preferred Shares Capital Increase | -63.0K | -804.0K | -67.0K | |||
| Increase Decrease Through Exercise Of Options | $938.0K | $274.0K | $120.0K | |||
| Interest Received Classified As Operating Activities | $1.5M | $1.2M | $126.0K | |||
| Transactions Cost Related To Business Combination Agreement | $4.6M | $214.0K |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.